Clinical Trials Directory

Trials / Completed

CompletedNCT05431517

Incidence, Risk Factors and Endoscopic Retrieval of Proximally Migrated Pancreatic Stents

Incidence, Risk Factors and Endoscopic Retrieval of Proximally Migrated Pancreatic Stents: 25 Years of Experience in a Tertiary Center

Status
Completed
Phase
Study type
Observational
Enrollment
9,073 (actual)
Sponsor
Changhai Hospital · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This study intends to determine the incidence, risk factors and endoscopic treatment of proximally migrated pancreatic stents.

Detailed description

Endoscopic pancreatic stenting can be used to treat a variety of pancreatic disorders, including chronic pancreatitis-induced pancreatic duct stenosis, pancreatic schizophrenia, pancreatic leakage, pancreatic pseudocyst drainage, and prophylactic pancreatic duct stenting. Postoperative stent migration is one of the complications associated with pancreatic stent placement. In this retrospective study, more than 9,000 Endoscopic retrograde cholangiopancreatography (ERCP) cases at our center over the past 25 years will be analyzed to determine the incidence, risk factors and endoscopic treatment of proximally migrated pancreatic stents.

Conditions

Interventions

TypeNameDescription
PROCEDUREAnalysis of ERCP recordsData will be extracted from ERCP records of stenting, mainly including: 1) Age at the time of ERCP; 2) Gender; 3) Indication; 4) Papilla selection (major or minor); 5) Whether endoscopic sphincterotomy (EST) was performed; 6) Presence of nipple diverticulum; 7) Morphology of the pancreatic duct; 8) Status of pancreatic duct stones; 9) Number, shape, material, diameter and length of the stent; and 10) Operation of the bile duct. Additional data were extracted from the pertinent ERCP records of stent migration: 1) Shape, material, diameter and length of the displaced stent; 2) Type of migration; and 3) Removal tools.

Timeline

Start date
2022-06-30
Primary completion
2022-07-01
Completion
2022-07-31
First posted
2022-06-24
Last updated
2022-09-14

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05431517. Inclusion in this directory is not an endorsement.